Medicare recipients who take expensive prescriptions will get a break this year with a $2,000 cap on drug costs.

Acelyrin (SLRN) stock dropped 32% after Phase 2 trial results for lonigutamab its experimental treatment for thyroid eye disease. Read more here.

Alphaf-001 is under clinical development by Alpha Fusion and currently in Phase I for Follicular Thyroid Cancer.

THREE years ago, my life changed in ways I could never have imagined.  I was 23, living what I thought was a healthy life, when seemingly out of nowhere, my body began to betray me.  I ...

The thyroid, a butterfly-shaped gland in the neck, produces hormones essential for metabolism and brain activity. Symptoms of ...

The FDA rejected sotagliflozin (Zynquista) as an adjunct to insulin therapy for glycemic control in adults with type 1 ...

By aiding weight loss, Zepbound can improve symptoms of obstructive sleep apnea (OSA) in people with obesity — but CPAP ...

after increasing the price of a thyroid disease drug by 1,110% over an eight-year period. The Competition and Markets Authority (CMA) said the fine "sends a clear message" to the pharmaceutical ...

The following chart lists drugs that may interact with Ozempic ... A personal or family history of thyroid cancer. Doctors usually will not prescribe Ozempic to people with a personal or family ...

For every illegal drug, there is a combination of emojis that dealers and consumers use to evade detection on social media and messaging platforms. Snowflakes, snowfall, and snowmen symbolize cocaine.